Virulence determinants in community and hospital meticillin-resistant Staphylococcus aureus

Oliveira, 2002, Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus, Lancet Infect Dis, 2, 180, 10.1016/S1473-3099(02)00227-X

Baba, 2002, Genome and virulence determinants of high virulence communityacquired MRSA, Lancet, 359, 1819, 10.1016/S0140-6736(02)08713-5

Ferry, 2005, Comparative prevalence of superantigen genes in Staphylococcus aureus isolates causing sepsis with and without septic shock, Clin Infect Dis, 41, 771, 10.1086/432798

Lina, 1999, Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia, Clin Infect Dis, 29, 1128, 10.1086/313461

Robinson, 2003, Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus, Antimicrob Agents Chemother, 47, 3926, 10.1128/AAC.47.12.3926-3934.2003

Dauwalder, 2006, Comparative inflammatory properties of staphylococcal superantigenic enterotoxins SEA and SEG: implications for septic shock, J Leukoc Biol, 80, 753, 10.1189/jlb.0306232

Garnier, 2006, Pneumonia and new methicillin-resistant Staphylococcus aureus clone, Emerg Infect Dis, 12, 498, 10.3201/eid1203.051040

Naimi, 2003, Comparison of communityand health care-associated methicillinresistant Staphylococcus aureus infection, JAmMed Assoc, 290, 2976, 10.1001/jama.290.22.2976

Bocchini, 2006, Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children, Pediatrics, 117, 433, 10.1542/peds.2005-0566

Vandenesch, 2003, Communityacquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence, Emerg Infect Dis, 9, 978, 10.3201/eid0908.030089

Chalumeau, 2005, Transmission of Panton-Valentine leukocidin-producing Staphylococcus aureus to a physician during resuscitation of a child, Clin Infect Dis, 41, e29, 10.1086/431762

Hsu, 2005, Community associated methicillin-resistant Staphylococcus aureus, Singapore, Emerg Infect Dis, 11, 341, 10.3201/eid1102.040782

Kourbatova, 2005, Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections, Am J Infect Control, 33, 385, 10.1016/j.ajic.2005.06.006

Cheung, 2002, The genomic aspect of virulence, sepsis, and resistance to killing mechanisms in Staphylococcus aureus, Curr Infect Dis Rep, 4, 400, 10.1007/s11908-002-0006-2

Dinges, 2000, Exotoxins of Staphylococcus aureus, Clin Microbiol Rev, 13, 16, 10.1128/CMR.13.1.16-34.2000

Finck-Barbancon, 1993, Pore formation by a two-component leukocidin from Staphylococcus aureus within the membrane of human polymorphonuclear leukocytes, Biochim Biophys Acta, 1182, 275, 10.1016/0925-4439(93)90069-D

Cribier, 1992, Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study, Dermatology, 185, 175, 10.1159/000247443

Gillet, 2002, Association between Staphylococcus aureus strains carrying gene for PantonValentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients, Lancet, 359, 753, 10.1016/S0140-6736(02)07877-7

Yamaguchi, 2002, Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillinresistant clonal groups in Kansai district in Japan, J Infect Dis, 185, 1511, 10.1086/340212

Liassine, 2004, Community-acquired methicillin-resistant Staphylococcus aureus isolated in Switzerland contains the Panton-Valentine leukocidin or exfoliative toxin genes, J Clin Microbiol, 42, 825, 10.1128/JCM.42.2.825-828.2004

Ladhani, 1999, Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome, Clin Microbiol Rev, 12, 224, 10.1128/CMR.12.2.224

Kikuchi, 2003, Molecular epidemiology of methicillinresistant Staphylococcus aureus strains causing neonatal toxic shock syndrome-like exanthematous disease in neonatal and perinatal wards, J Clin Microbiol, 41, 3001, 10.1128/JCM.41.7.3001-3006.2003

Floret, 2001, [Clinical aspects of streptococcal and staphylococcal toxinic diseases], Arch Pediatr, 8, 762s, 10.1016/S0929-693X(01)80194-9

van der Mee-Marquet, 2003, Staphylococcal exanthematous disease in a newborn due to a virulent methicillin-resistant Staphylococcus aureus strain containing the TSST-1 gene in Europe: an alert for neonatologists, J Clin Microbiol, 41, 4883, 10.1128/JCM.41.10.4883-4884.2003

Durand, 2006, Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospitaland community-acquired infections in France, J Clin Microbiol, 44, 847, 10.1128/JCM.44.3.847-853.2006

Peacock, 2002, Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus, Infect Immun, 70, 4987, 10.1128/IAI.70.9.4987-4996.2002